Glenview Capital Management, LLC Evolus, Inc. Transaction History

Glenview Capital Management, LLC

  • $5.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$10.22 - $13.94 $4.03 Million - $5.5 Million
-394,810 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$5.22 - $11.78 $5,131 - $11,579
983 Added 0.25%
394,810 $4.43 Million
Q4 2021

Feb 14, 2022
BUY
$5.37 - $8.38 $2.11 Million - $3.3 Million
393,827 New
393,827 $2.56 Million

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email